| Field | Row 1 |
|---|---|
| adsh | 0001628280-25-023635 |
| cik | 1337013 |
| name | INFUSYSTEM HOLDINGS, INC |
| sic | 3841 |
| countryba | US |
| stprba | MI |
| cityba | ROCHESTER HILLS |
| zipba | 48309 |
| bas1 | 3851 WEST HAMLIN ROAD |
| bas2 | |
| baph | (248) 291-1210 |
| countryma | US |
| stprma | MI |
| cityma | ROCHESTER HILLS |
| zipma | 48309 |
| mas1 | 3851 WEST HAMLIN ROAD |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 203341405 |
| former | HAPC, INC. |
| changed | 20060425 |
| afs | 2-ACC |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 13:13:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | infu-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-023635 | 20241231 | Inventory Net | 6528000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Accounts Receivable Net Current | 23892000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | 159000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | 159000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1057000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Amortization Of Intangible Assets | 248000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Assets | 44854000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20241231 | Assets | 103614000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 527000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Common Stock Shares Issued | 20973616.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Common Stock Shares Outstanding | 21272351.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Common Stock Shares Outstanding | 20974000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Comprehensive Income Net Of Tax | -516000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Goodwill | 3710000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Device Solutions; | ||
| 0001628280-25-023635 | 20250331 | Gross Profit | 19167000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Increase Decrease In Accounts Receivable | 237000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Increase Decrease In Inventories | -153000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Increase Decrease In Other Current Assets | -126000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Increase Decrease In Other Noncurrent Assets | -729000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Intangible Assets Net Excluding Goodwill | 6456000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Net Cash Provided By Used In Financing Activities | 1860000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Net Cash Provided By Used In Investing Activities | -2661000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Net Income Loss | -267000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Operating Lease Right Of Use Asset | 5374000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Operating Lease Right Of Use Asset | 5244000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Other Liabilities Current | 7602000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Payments For Repurchase Of Common Stock | 2895000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Property Plant And Equipment Net | 1592000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Furniture And Fixtures; | ||
| 0001628280-25-023635 | 20250331 | Property Plant And Equipment Net | 3922000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Repayments Of Long Term Debt And Capital Securities | 15258000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Repayments Of Long Term Debt And Capital Securities | 14407000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Revenues | 34716000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20231231 | Stockholders Equity | 52302000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20231231 | Stockholders Equity | 109837000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20241231 | Stockholders Equity | 1119000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent; | ||
| 0001628280-25-023635 | 20240331 | Stock Issued During Period Shares Share Based Compensation Gross | 106000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 21125019.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Assets Current | 32165000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Assets | 57996000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Assets | 1683000.0000 | USD | 0 | us-gaap/2024 | Lease Classification= Sales Type Lease Net Investment; | ||
| 0001628280-25-023635 | 20250331 | Assets Current | 35322000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Cash And Cash Equivalents At Carrying Value | 527000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 231000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Common Stock Shares Outstanding | 21272000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Deferred Income Tax Assets Net | 6749000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Deferred Income Tax Expense Benefit | 520000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Depreciation | 2652000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Earnings Per Share Basic | -0.0100 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Gross Profit | 16474000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Gross Profit | 12274000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20240331 | Income Tax Expense Benefit | -186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Increase Decrease In Other Current Assets | 685000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Inventory Net | 6095000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Liabilities | 46085000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Liabilities And Stockholders Equity | 103614000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Long Term Debt Noncurrent | 28707000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Medical Equipment In Rental Service Net Of Accumulated Depreciation | 39175000.0000 | USD | 0 | 0001628280-25-023635 | |||
| 0001628280-25-023635 | 20250331 | Medical Equipment In Rental Service Net Of Accumulated Depreciation | 38615000.0000 | USD | 0 | 0001628280-25-023635 | |||
| 0001628280-25-023635 | 20240331 | Net Income Loss | -1112000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | -80000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 208000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | 208000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-023635 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -249000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Other Liabilities Current | 7813000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Other Nonoperating Income Expense | -29000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Payments To Acquire Property Plant And Equipment | 182000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Proceeds From Payments For Other Financing Activities | 16069000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Proceeds From Sale Of Productive Assets | 1257000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Proceeds From Stock Plans | 186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Property Plant And Equipment Net | 2438000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Leasehold Improvements; | ||
| 0001628280-25-023635 | 20250331 | Property Plant And Equipment Net | 1573000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Furniture And Fixtures; | ||
| 0001628280-25-023635 | 20241231 | Retained Earnings Accumulated Deficit | -57460000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Shares Paid For Tax Withholding For Share Based Compensation | 39000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20231231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20241231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Stockholders Equity | 870000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent; | ||
| 0001628280-25-023635 | 20250331 | Stock Issued During Period Shares Share Based Compensation Gross | 79000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20241231 | Accounts Payable Current | 9848000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 237000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20240331 | Amortization Of Financing Costs | 19000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Assets | 2000000.0000 | USD | 0 | us-gaap/2024 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 822000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Common Stock Shares Issued | 21272351.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20231231 | Common Stock Shares Outstanding | 21197000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20240331 | Common Stock Shares Outstanding | 21290000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Deferred Income Tax Assets Net | 7188000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Earnings Per Share Diluted | -0.0500 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Earnings Per Share Diluted | -0.0100 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Intangible Assets Net Excluding Goodwill | 6208000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Interest Expense Nonoperating | 456000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Net Cash Provided By Used In Financing Activities | 632000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Net Cash Provided By Used In Operating Activities | 1780000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Net Income Loss | -1112000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20250331 | Operating Lease Liability Noncurrent | 4458000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Other Assets Noncurrent | 878000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Proceeds From Sale Of Productive Assets | 754000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Revenues | 31995000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Revenues | 15117000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Revenues | 15824000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Revenues | -1882000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20240331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20240331 | Stockholders Equity | -59737000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20241231 | Stockholders Equity | 1119000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-023635 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 365000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20240331 | Assets | 104850000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Comprehensive Income Net Of Tax | -904000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Deferred Income Tax Expense Benefit | -186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Derivative Assets Noncurrent | 1152000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | General And Administrative Expense | 13695000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | General And Administrative Expense | 15316000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Goodwill | 3710000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Gross Profit | 4200000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Gross Profit | 0.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 253000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Income Tax Expense Benefit | 520000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Increase Decrease In Inventories | -433000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Liabilities And Stockholders Equity | 104282000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Liabilities Current | 17661000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Medical Equipment Held For Sale Or Rental | 3157000.0000 | USD | 0 | 0001628280-25-023635 | |||
| 0001628280-25-023635 | 20250331 | Operating Expenses | 18549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Other Assets Noncurrent | 597000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 365000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 228000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Payments To Acquire Medical Equipment | 1493000.0000 | USD | 1 | 0001628280-25-023635 | |||
| 0001628280-25-023635 | 20250331 | Property Plant And Equipment Net | 0.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Automobiles; | ||
| 0001628280-25-023635 | 20240331 | Provision For Doubtful Accounts | -130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Provision For Doubtful Accounts | 45000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Retained Earnings Accumulated Deficit | -60622000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Selling And Marketing Expense | 3376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Shares Paid For Tax Withholding For Share Based Compensation | 30000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20231231 | Stockholders Equity | 1088000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent; | ||
| 0001628280-25-023635 | 20240331 | Stockholders Equity | 1296000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-023635 | 20240331 | Stockholders Equity | 110715000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20241231 | Stockholders Equity | -57460000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20250331 | Stock Repurchased And Retired During Period Shares | 382000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 21225768.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Liabilities | 49134000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Accounts Receivable Net Current | 2737000.0000 | USD | 0 | us-gaap/2024 | Restatement= Restatement Adjustment; | ||
| 0001628280-25-023635 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 1119000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Additional Paid In Capital | 113868000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 365000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Selling And Marketing Expense | 2985000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Amortization Of Financing Costs | 19000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Assets | 2000000.0000 | USD | 0 | us-gaap/2024 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20241231 | Assets | 1934000.0000 | USD | 0 | us-gaap/2024 | Lease Classification= Sales Type Lease Net Investment; | ||
| 0001628280-25-023635 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1506000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Common Stock Shares Outstanding | 20973616.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Cost Of Goods And Services Sold | 15549000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Depreciation | 3072000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Derivative Assets Noncurrent | 1481000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Earnings Per Share Basic | -0.0500 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Gain Loss On Disposition Of Assets | 629000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Gross Profit | 5982000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Gross Profit | 13185000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Impairment Of Long Lived Assets To Be Disposed Of | 257000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Increase Decrease In Accounts Receivable | 2095000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Interest Expense Nonoperating | 336000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Medical Equipment Held For Sale Or Rental | 2763000.0000 | USD | 0 | 0001628280-25-023635 | |||
| 0001628280-25-023635 | 20240331 | Net Cash Provided By Used In Investing Activities | -418000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Operating Expenses | 17319000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Operating Income Loss | -845000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Operating Income Loss | 618000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | 66000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -249000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-023635 | 20240331 | Payments To Acquire Medical Equipment | 350000.0000 | USD | 1 | 0001628280-25-023635 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20240331 | Payments To Acquire Medical Equipment | 0.0000 | USD | 1 | 0001628280-25-023635 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20250331 | Payments To Acquire Medical Equipment | 0.0000 | USD | 1 | 0001628280-25-023635 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Proceeds From Stock Plans | 159000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Property Plant And Equipment Net | 2349000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Leasehold Improvements; | ||
| 0001628280-25-023635 | 20250331 | Revenues | 20774000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20231231 | Stockholders Equity | 1088000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-023635 | 20240331 | Stockholders Equity | 52276000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Stockholders Equity | 55148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Additional Paid In Capital | 114898000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Amortization Of Intangible Assets | 248000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Assets | 48354000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 591000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 979000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Gain Loss On Disposition Of Assets | 838000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Goodwill | 3710000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Goodwill | 0.0000 | USD | 0 | us-gaap/2024 | Business Segments= Patient Services; | ||
| 0001628280-25-023635 | 20240331 | Impairment Of Long Lived Assets To Be Disposed Of | -43000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -1106000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Increase Decrease In Other Noncurrent Assets | -376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Liabilities Current | 15969000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Net Cash Provided By Used In Operating Activities | 377000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Net Income Loss | -267000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20250331 | Other Assets Current | 3829000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Payments To Acquire Medical Equipment | 1508000.0000 | USD | 1 | 0001628280-25-023635 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Property Plant And Equipment Net | 4030000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Stockholders Equity | 1296000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent; | ||
| 0001628280-25-023635 | 20250331 | Stockholders Equity | 114898000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 35000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 21125019.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Assets | 53928000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Cash And Cash Equivalents At Carrying Value | 1506000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Cost Of Goods And Services Sold | 15521000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Goodwill | 3710000.0000 | USD | 0 | us-gaap/2024 | Business Segments= Device Solutions; | ||
| 0001628280-25-023635 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -1298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Increase Decrease In Accounts Payable And Other Operating Liabilities | -1577000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent | 274000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent | -329000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Other Nonoperating Income Expense | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Payments For Repurchase Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Revenues | 18591000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20240331 | Revenues | -1713000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20240331 | Share Based Compensation | 1057000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Share Based Compensation | 1108000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Stockholders Equity | 113868000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20250331 | Stockholders Equity | 870000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001628280-25-023635 | 20250331 | Stock Repurchased And Retired During Period Value | 2895000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Accounts Payable Current | 8367000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Accounts Receivable Net Current | 21155000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 870000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 237000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | 186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | 186000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1057000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1108000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1108000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023635 | 20250331 | Assets | 104282000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Derivative Assets Noncurrent | 1481000.0000 | USD | 0 | us-gaap/2024 | Derivative Instrument Risk= Interest Rate Swap; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument; | ||
| 0001628280-25-023635 | 20250331 | Derivative Assets Noncurrent | 1152000.0000 | USD | 0 | us-gaap/2024 | Derivative Instrument Risk= Interest Rate Swap; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging; Hedging Designation= Designated As Hedging Instrument; | ||
| 0001628280-25-023635 | 20240331 | Gross Profit | 0.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Corporate And Eliminations; | ||
| 0001628280-25-023635 | 20241231 | Long Term Debt Noncurrent | 23864000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Operating Lease Liability Noncurrent | 4560000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Other Assets Current | 3955000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20240331 | Payments To Acquire Medical Equipment | 1143000.0000 | USD | 1 | 0001628280-25-023635 | Business Segments= Device Solutions; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Payments To Acquire Medical Equipment | 3284000.0000 | USD | 1 | 0001628280-25-023635 | |||
| 0001628280-25-023635 | 20250331 | Payments To Acquire Medical Equipment | 1776000.0000 | USD | 1 | 0001628280-25-023635 | Business Segments= Patient Services; Consolidation Items= Operating Segments; | ||
| 0001628280-25-023635 | 20250331 | Payments To Acquire Property Plant And Equipment | 131000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Proceeds From Payments For Other Financing Activities | 19231000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20241231 | Property Plant And Equipment Net | 0.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Automobiles; | ||
| 0001628280-25-023635 | 20231231 | Stockholders Equity | -58625000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20241231 | Stockholders Equity | 57529000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023635 | 20250331 | Stockholders Equity | -60622000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20240331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 26000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023635 | 20250331 | Stock Repurchased And Retired During Period Value | 2895000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023635 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 21225768.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Impairment Of Long Lived Assets To Be Disposed Of | us-gaap/2024 | 0 | 0 | monetary | D | D | Impairment of Long-Lived Assets to be Disposed of | The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Adjustments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation | Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Parent | Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness, attributable to parent. |
| Selling And Marketing Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Repayments Of Long Term Debt And Capital Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security | Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition | Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Stock Repurchased And Retired During Period Shares | us-gaap/2024 | 0 | 0 | shares | D | Stock Repurchased and Retired During Period, Shares | Number of shares that have been repurchased and retired during the period. | |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Medical Equipment Held For Sale Or Rental | 0001628280-25-023635 | 1 | 0 | monetary | I | D | Medical Equipment Held For Sale Or Rental | Represents medical equipment held for sale or rental as of the balance sheet date. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Medical Equipment In Rental Service Net Of Accumulated Depreciation | 0001628280-25-023635 | 1 | 0 | monetary | I | D | Medical Equipment In Rental Service, Net Of Accumulated Depreciation | Represents medical equipment in rental service, net of accumulated depreciation, as of the balance sheet date. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Sale Of Productive Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Productive Assets | The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. |
| Stock Issued During Period Shares Share Based Compensation Gross | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture | Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | |
| Stock Repurchased And Retired During Period Value | us-gaap/2024 | 0 | 0 | monetary | D | D | Stock Repurchased and Retired During Period, Value | Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). |
| Deferred Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
| Proceeds From Payments For Other Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Amortization Of Financing Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Increase Decrease In Other Current Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Current Assets | Amount of increase (decrease) in current assets classified as other. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| Proceeds From Stock Plans | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Plans | The cash inflow associated with the amount received from the stock plan during the period. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gain Loss On Disposition Of Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent | Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent. |
| Payments For Repurchase Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Paid For Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Payments To Acquire Medical Equipment | 0001628280-25-023635 | 1 | 0 | monetary | D | C | Payments To Acquire Medical Equipment | Represents the amount of cash paid during the period to acquire medical equipment. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Derivative Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Derivative Asset, Noncurrent | Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-023635 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001628280-25-023635 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001628280-25-023635 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories, net | 0 |
| 0001628280-25-023635 | 2 | 6 | BS | 0 | H | Other Assets Current | us-gaap/2024 | Other current assets | 0 |
| 0001628280-25-023635 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001628280-25-023635 | 2 | 8 | BS | 0 | H | Medical Equipment Held For Sale Or Rental | 0001628280-25-023635 | Medical equipment for sale or rental | 0 |
| 0001628280-25-023635 | 2 | 9 | BS | 0 | H | Medical Equipment In Rental Service Net Of Accumulated Depreciation | 0001628280-25-023635 | Medical equipment in rental service, net of accumulated depreciation | 0 |
| 0001628280-25-023635 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property & equipment, net of accumulated depreciation | 0 |
| 0001628280-25-023635 | 2 | 11 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001628280-25-023635 | 2 | 12 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net | 0 |
| 0001628280-25-023635 | 2 | 13 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right of use assets | 0 |
| 0001628280-25-023635 | 2 | 14 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred income taxes | 0 |
| 0001628280-25-023635 | 2 | 15 | BS | 0 | H | Derivative Assets Noncurrent | us-gaap/2024 | Derivative financial instruments | 0 |
| 0001628280-25-023635 | 2 | 16 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001628280-25-023635 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001628280-25-023635 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001628280-25-023635 | 2 | 21 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
| 0001628280-25-023635 | 2 | 22 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001628280-25-023635 | 2 | 23 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Long-term debt | 0 |
| 0001628280-25-023635 | 2 | 24 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0001628280-25-023635 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001628280-25-023635 | 2 | 27 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued | 0 |
| 0001628280-25-023635 | 2 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,973,616 shares issued and outstanding as of March 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 | 0 |
| 0001628280-25-023635 | 2 | 29 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001628280-25-023635 | 2 | 30 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0001628280-25-023635 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Retained deficit | 0 |
| 0001628280-25-023635 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001628280-25-023635 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001628280-25-023635 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001628280-25-023635 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, authorized (in shares) | 0 |
| 0001628280-25-023635 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, issued (in shares) | 0 |
| 0001628280-25-023635 | 3 | 4 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001628280-25-023635 | 3 | 5 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, authorized (in shares) | 0 |
| 0001628280-25-023635 | 3 | 6 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, issued (in shares) | 0 |
| 0001628280-25-023635 | 3 | 7 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, outstanding (in shares) | 0 |
| 0001628280-25-023635 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Net revenues | 0 |
| 0001628280-25-023635 | 4 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of revenues | 0 |
| 0001628280-25-023635 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001628280-25-023635 | 4 | 5 | IS | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangibles | 0 |
| 0001628280-25-023635 | 4 | 6 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2024 | Selling and marketing | 0 |
| 0001628280-25-023635 | 4 | 7 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001628280-25-023635 | 4 | 8 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total selling, general and administrative | 0 |
| 0001628280-25-023635 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating income (loss) | 0 |
| 0001628280-25-023635 | 4 | 11 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 1 |
| 0001628280-25-023635 | 4 | 12 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other expense (income) | 0 |
| 0001628280-25-023635 | 4 | 13 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income (loss) before income taxes | 0 |
| 0001628280-25-023635 | 4 | 14 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | (Provision for) benefit from income taxes | 1 |
| 0001628280-25-023635 | 4 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-023635 | 4 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic (in dollars per share) | 0 |
| 0001628280-25-023635 | 4 | 18 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted (in dollars per share) | 0 |
| 0001628280-25-023635 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic (in shares) | 0 |
| 0001628280-25-023635 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted (in shares) | 0 |
| 0001628280-25-023635 | 4 | 23 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-023635 | 4 | 25 | IS | 0 | H | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent | us-gaap/2024 | Unrealized (loss) gain on hedges | 0 |
| 0001628280-25-023635 | 4 | 26 | IS | 0 | H | Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent | us-gaap/2024 | Benefit from (provision for) income tax on unrealized hedge gain | 1 |
| 0001628280-25-023635 | 4 | 27 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Net comprehensive loss | 0 |
| 0001628280-25-023635 | 5 | 10 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001628280-25-023635 | 5 | 11 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001628280-25-023635 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation Gross | us-gaap/2024 | Shares issued upon restricted stock vesting and option exercise (in shares) | 0 |
| 0001628280-25-023635 | 5 | 13 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0001628280-25-023635 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | Employee stock purchase plan (in shares) | 0 |
| 0001628280-25-023635 | 5 | 15 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | us-gaap/2024 | Employee stock purchase plan | 0 |
| 0001628280-25-023635 | 5 | 16 | EQ | 0 | H | Stock Repurchased And Retired During Period Shares | us-gaap/2024 | Common stock repurchased as part of share repurchase program (in shares) | 1 |
| 0001628280-25-023635 | 5 | 17 | EQ | 0 | H | Stock Repurchased And Retired During Period Value | us-gaap/2024 | Common stock repurchased as part of share repurchase program | 1 |
| 0001628280-25-023635 | 5 | 18 | EQ | 0 | H | Shares Paid For Tax Withholding For Share Based Compensation | us-gaap/2024 | Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation (in shares) | 1 |
| 0001628280-25-023635 | 5 | 19 | EQ | 0 | H | Adjustments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Common stock repurchased to satisfy minimum statutory withholding on stock-based compensation | 1 |
| 0001628280-25-023635 | 5 | 20 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Other comprehensive income (loss) | 0 |
| 0001628280-25-023635 | 5 | 21 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-023635 | 5 | 22 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001628280-25-023635 | 5 | 23 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001628280-25-023635 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-023635 | 6 | 4 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Provision for doubtful accounts | 0 |
| 0001628280-25-023635 | 6 | 5 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001628280-25-023635 | 6 | 6 | CF | 0 | H | Impairment Of Long Lived Assets To Be Disposed Of | us-gaap/2024 | Loss (gain) on disposal of and reserve adjustments for medical equipment | 0 |
| 0001628280-25-023635 | 6 | 7 | CF | 0 | H | Gain Loss On Disposition Of Assets | us-gaap/2024 | Gain on sale of medical equipment | 1 |
| 0001628280-25-023635 | 6 | 8 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible assets | 0 |
| 0001628280-25-023635 | 6 | 9 | CF | 0 | H | Amortization Of Financing Costs | us-gaap/2024 | Amortization of deferred debt issuance costs | 0 |
| 0001628280-25-023635 | 6 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001628280-25-023635 | 6 | 11 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2024 | Deferred income taxes | 0 |
| 0001628280-25-023635 | 6 | 13 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001628280-25-023635 | 6 | 14 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
| 0001628280-25-023635 | 6 | 15 | CF | 0 | H | Increase Decrease In Other Current Assets | us-gaap/2024 | Other current assets | 1 |
| 0001628280-25-023635 | 6 | 16 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other assets | 1 |
| 0001628280-25-023635 | 6 | 18 | CF | 0 | H | Increase Decrease In Accounts Payable And Other Operating Liabilities | us-gaap/2024 | Accounts payable and other liabilities | 0 |
| 0001628280-25-023635 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH PROVIDED BY OPERATING ACTIVITIES | 0 |
| 0001628280-25-023635 | 6 | 21 | CF | 0 | H | Payments To Acquire Medical Equipment | 0001628280-25-023635 | Purchase of medical equipment | 1 |
| 0001628280-25-023635 | 6 | 22 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001628280-25-023635 | 6 | 23 | CF | 0 | H | Proceeds From Sale Of Productive Assets | us-gaap/2024 | Proceeds from sale of medical equipment, property and equipment | 0 |
| 0001628280-25-023635 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | NET CASH USED IN INVESTING ACTIVITIES | 0 |
| 0001628280-25-023635 | 6 | 26 | CF | 0 | H | Repayments Of Long Term Debt And Capital Securities | us-gaap/2024 | Principal payments on long-term debt | 1 |
| 0001628280-25-023635 | 6 | 27 | CF | 0 | H | Proceeds From Payments For Other Financing Activities | us-gaap/2024 | Cash proceeds from long-term debt | 0 |
| 0001628280-25-023635 | 6 | 28 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2024 | Common stock repurchased as part of share repurchase program | 1 |
| 0001628280-25-023635 | 6 | 29 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans | 1 |
| 0001628280-25-023635 | 6 | 30 | CF | 0 | H | Proceeds From Stock Plans | us-gaap/2024 | Cash proceeds from exercise of options and ESPP | 0 |
| 0001628280-25-023635 | 6 | 31 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | NET CASH PROVIDED BY FINANCING ACTIVITIES | 0 |
| 0001628280-25-023635 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash and cash equivalents | 0 |
| 0001628280-25-023635 | 6 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, beginning of period | 0 |
| 0001628280-25-023635 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, end of period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |